# Pharmacokinetic Study Comparing Aspirin and Aspirin Granules

> **NCT01072604** · PHASE1 · COMPLETED · sponsor: **Bayer** · enrollment: 30 (actual)

## Conditions studied

- Pharmacokinetics

## Interventions

- **DRUG:** Acetylsalicylic acid (Aspirin, BAY1019036)
- **DRUG:** Acetylsalicylic acid (Aspirin, BAY1019036)
- **DRUG:** Acetylsalicylic acid (Aspirin, BAYE4465)
- **DRUG:** Acetylsalicylic acid (Aspirin, BAYE4465)

## Key facts

- **NCT ID:** NCT01072604
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-07
- **Primary completion:** 2009-08
- **Final completion:** 2009-08
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2014-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01072604

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01072604, "Pharmacokinetic Study Comparing Aspirin and Aspirin Granules". Retrieved via AI Analytics 2026-06-21 from https://api.ai-analytics.org/clinical/NCT01072604. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*